Quarterly Financial Watch for TrovaGene, Inc. (NASDAQ:TROV)

3

Quarterly Sales and EPS Roundup:

TrovaGene, Inc. (TROV) reported sales (ttm) of 400000. The year ago reported sale was 3.73 million.

TrovaGene, Inc. (TROV) reported earning per shares for the quarter ending Aug 09 AMC, whereas, 1 number of analysts estimated the mean EPS at -0.24. The analysts estimated EPS for the higher end at -0.24 and lower end at -0.24 while the year ago reported earnings per share was -0.22.

The company has mean EPS estimate of -0.24 reported by 1 number of analyst for the quarter ending Current Qtr.(Jun2017). The analysts estimated mean EPS at -0.24 while the high and low EPS estimate stand at -0.24 and -0.24 respectively. In contrast to the year ago quarter EPS was at -0.21.

Valuation Ratios of TrovaGene, Inc. (TROV) versus the Industry and Sector:

Let’s have a look at some of the important valuation ratios of the TrovaGene, Inc. (TROV). These ratios are important while doing valuation of the company or the shares of the company.

TrovaGene, Inc. (TROV) currently has P/E (Price to Earnings) ratio of 0 while the company’s industry has 33 P/E and the sector P/E is 17.23. Similarly, the company’s last 5 years high P/E ratio is 0 and low P/E is 0, whereas, the industry’s and sector’s  high P/E for the past year is 41.46 and 43.61 respectively and low P/E ratio for the last 5 years is 21.15 for the industry and 23.34 for the Sector.

Beta is also an important valuation ratio for analyzing the stock of the company, TROV has Beta of 0.44 while its industry and Sector’s beta remains at 0.76 and 0.89 respectively.

Price to Sale ratio of TROV stands at 97.55 while Price to Book Ratio stands at 3.25. Its Price to Cash Flow ratio shows the value of 0, whereas, the industry and sector ratio of Price to Cash Flow ticked at 20.57 and 10.42 respectively.

5 Year Growth Rate Analysis:

Growth rates are very important while analyzing the long term growth and valuation of a certain company.

5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of TrovaGene, Inc. (TROV) stands at 8.14 while the industry’s and the sector’s growth for next 5 years ticked at 8.88 and 10.49 respectively.

TrovaGene, Inc. (TROV) Trading Statistics:

The company declined -20.57% and closed its last trading session at $1.41. The market capitalization of the company is at $43.7 Million. The stock touched 52-week High of $5.98 on 08/17/16 and 52-week Low of $0.61 on 05/31/17. The stock currently has Weekly Volatility of 11.02% and Monthly Volatility of 13.53%. The Beta for the company stands at 0.45 and its Average True Range (ATR) shows a value of 0.17.

 

SHARE